News from glenmark pharmaceuticals ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

12 Sep, 2017, 08:00 BST New Survey Reveals Almost Half of UK Adults Who Travel to Malaria-risk Areas do not Think that they need Antimalarial Protection[1] Despite NHS' Recommendation[2]

New research[1] of over 1,000 UK adults highlights that almost half (48%) of those who travel to areas at risk of malaria may be leaving themselves...


03 Sep, 2015, 13:36 BST Glenmark's Novel Monoclonal Antibody GBR 830 to Enter Phase 2 Clinical Studies in Atopic Dermatitis and Celiac Disease in US and Europe

- GBR 830 Completes Clinical Phase 1 Successfully in The Netherlands - The Antibody has Been Well Tolerated With a Favourable Pharmacokinetic Profile ...


26 Mar, 2015, 11:12 GMT Glenmark's Pithampur Plant in Madhya Pradesh, India Wins MPFCCI Outstanding Achievement Award 2014 for Excellence in Health & Safety

Honourable Chief Minister of Madhya Pradesh - Shivraj Singh Chauhan Presented the Award in a Ceremony Attended by More Than 500 Personnel From...


05 Nov, 2014, 06:05 GMT Glenmark Generics Receives Final ANDA Approval for Omeprazole DR Capsules

Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application...


30 Oct, 2014, 17:25 GMT Glenmark's Consolidated Revenue Increases by 14.85% to Rs. 16,807.08 Mn in Q2 FY 14-15

Net Profit for the second quarter increases by 7% to Rs 1650.78 Mn Business Highlights India Business grew by 14.48 % to Rs. 4,781.50 Mn Latin...


28 Oct, 2014, 09:19 GMT Glenmark Facilitates 'PharmaEDGE'- A Unique Continuing Professional Development (CPD) Program for Pharmacists of MENA Countries

PharmaEDGE, a unique Continuing Professional Development (CPD) Program for pharmacists of Middle East and North African (MENA) countries was...


25 Sep, 2014, 08:25 BST Glenmark Conferred Civic Award 2013-14 for Social Development by the Bombay Chamber of Commerce and Industry

Presented the Prestigious Distinction for Exemplary Initiatives in the Area of Corporate Social Responsibility Glenmark Pharmaceuticals Limited, the...


20 Aug, 2014, 11:05 BST Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody

Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and...


17 Jul, 2014, 12:11 BST Glenmark Pharmaceuticals to Set up a New Manufacturing Facility in the US

- The Facility Will be Situated in Monroe, North Carolina, USA - It Will Manufacture Oral Solids, Injectables and Topicals Over a Five Year Period...


03 Jul, 2014, 14:04 BST Glenmark's Novel Monoclonal Antibody GBR 830 for Treatment of Autoimmune Diseases Entering Human Trials

GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting OX40, a...


02 Jul, 2014, 14:50 BST Doctors' Role Commemorated on Doctor's Day by Creating World's Largest Pet Bottle Mosaic in the Shape of a Smile at JJ Hospital, Mumbai

~All the expectorant pet bottles used in creating this smiley are to be donated to 32 Government Hospitals across the country to provide relief to...


03 Apr, 2014, 14:28 BST Glenmark's Novel Molecule 'GRC 27864' for Chronic Inflammatory Diseases Including Pain Entering Human Trials

GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1 The molecule has successfully completed pre-clinical and Phase 1 enabling...


23 Dec, 2013, 13:03 GMT mMitra, a Free Voice Messaging Health Advisory Service Launched for Pregnant Women & Mothers at Sion Hospital, Mumbai

First of its kind public-private partnership between an NGO, Corporate and Government Institution, coming together for a social cause mMitra, a free...


02 Dec, 2013, 07:55 GMT Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business

Glenmark Pharmaceuticals announces the appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API business. Phil has...


31 Oct, 2013, 14:08 GMT Glenmark's Consolidated Revenue Increases by 16.56% to Rs. 14630.06 Mn for Q2 FY 13-14

Net Profit for the second quarter was Rs 1542.97 Mn as compared to Rs. 1567.52 mn for the previous corresponding quarter Highlights: Q2-FY14 -Results ...


29 Oct, 2013, 09:17 GMT 'EDGE' - An Internationally Accredited Innovative Dermatology CME Program Held in United Arab Emirates and the Sultanate of Oman on 11th - 12th October, 2013

'EDGE (Excellence in Dermatology a Global InitiativE)' an internationally accredited continuing medical education (CME) program for cosmetologists,...


23 Jul, 2013, 15:24 BST Glenmark Pharmaceuticals Announces Launch of its Child Health CSR Programme in Kenya

Glenmark, the leading research-driven, global, integrated pharmaceutical company has announced the launch of its Child Health Corporate Social...


26 Jun, 2013, 08:03 BST Glenmark Foundation' Announces Positive Impact of its Child Health Programme in Madhya Pradesh Focused on the Marginalized Korku Tribe

Shri Mahendra Hardia, Honorable Health Minister, Madhya Pradesh graces the occasion along with other dignitaries from the State Government In a span...


07 Feb, 2013, 15:32 GMT Atovaquone Proguanil (Malarone®) Patent Revoked & Glenmark Launches First UK Generic

Glenmark Generics (Europe) Limited (GGEL) announces the first generic launch of Atovaquone Proguanil in the UK following the revocation of the...


04 Feb, 2013, 11:08 GMT Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule OX40, also known as CD134, plays a key...


04 Feb, 2013, 11:08 GMT Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule OX40, also known as CD134, plays a key...


04 Feb, 2013, 10:09 GMT Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the First Antagonistic Antibody Targeting OX40 and is a Potential Global First-in-class Molecule - OX40, Also Known as CD134, Plays a...


30 Jan, 2013, 04:43 GMT Glenmark's Consolidated Revenue Increases by 33.96% to Rs. 13812.59 Million for Q3 FY 12-13

Net Profit for the Third Quarter was Rs. 2129.17 Mn as Compared to Rs. 448.24 Mn for the Previous Corresponding Quarter Highlights: Q3-FY13 - Results ...


02 Jan, 2013, 09:43 GMT USFDA Approves Crofelemer 125 mg Delayed-release Tablets for the Symptomatic Relief of Diarrhea in Patients With HIV/AIDS on Anti-Retroviral Therapy (ART)

This Will be the First NCE (New Chemical Entity) Launch by an Indian Company Across Multiple Geographies Glenmark Pharmaceuticals Limited announced...


30 Nov, 2012, 09:25 GMT Mr. Glenn Saldanha Honoured With 'Swiss Ambassador's Award for Exceptional Innovation'

Mr. Glenn Saldanha Becomes the Third Recipient of This Prestigious Award After Mr. Ratan Tata, Chairman, Tata Group in 2011 and Mr. Yash Chopra in...